Perimenopause, the years leading up to the final menstrual period, brings hormonal fluctuations that can trigger intense hunger, increased cravings, and a sense that eating patterns have shifted beyond your control. These changes are not a failure of willpower. They reflect measurable shifts in the hormones that regulate appetite, satiety, and blood glucose.

The hunger of perimenopause is driven by declining estrogen and its downstream effects on ghrelin, leptin, and GLP-1, and targeted supplements can address these specific hormonal pathways.

This article covers the hormonal basis of perimenopause hunger, the supplements with evidence for appetite regulation, and how to evaluate whether a product targets the mechanisms relevant to this life stage.

Why Perimenopause Changes Appetite

The hormonal shifts of perimenopause are not linear. Estrogen levels fluctuate unpredictably, sometimes spiking above pre-menopausal levels and sometimes dropping sharply. These fluctuations disrupt the hormonal systems that regulate hunger and fullness.

Estrogen normally suppresses appetite in part by reducing the sensitivity to ghrelin, the hormone produced in the stomach that signals hunger. When estrogen fluctuates and declines, ghrelin sensitivity increases, and hunger signals become stronger and more frequent. Research shows that perimenopausal women have higher ghrelin levels and altered ghrelin pulsatility compared to premenopausal women, contributing to increased hunger.¹

Leptin, the hormone produced by fat cells that signals satiety, is also affected. Studies indicate that leptin sensitivity can decrease during the menopausal transition, meaning that the brain receives weaker satiety signals even when leptin levels are normal or elevated.² This leptin resistance contributes to the feeling of never being full, particularly for carbohydrate-rich and high-fat foods.

GLP-1, the hormone that signals fullness and helps regulate post-meal blood glucose, is influenced by estrogen. As estrogen declines, GLP-1 production may also decrease, reducing the post-meal satiety response that normally helps people stop eating.³

Terms to Know!

• Ghrelin: a hormone produced primarily in the stomach that stimulates hunger. It rises before meals and falls after eating. Higher ghrelin levels or increased ghrelin sensitivity contribute to persistent hunger.
• Leptin resistance: a state in which the brain becomes less responsive to leptin signals, leading to reduced satiety even when fat stores are adequate. It is associated with weight gain and difficulty controlling appetite.

Supplements With Evidence for Appetite Regulation

When evaluating appetite supplements for perimenopause, the relevant question is whether the ingredients have been studied for their effects on ghrelin, leptin, GLP-1, or related appetite pathways. Generic appetite suppressants without mechanism-specific evidence provide little basis for expectations.

Eriomin and GLP-1 Support

Eriomin is a citrus flavonoid blend that has been studied for its effect on endogenous GLP-1 production. A randomized controlled trial found that Eriomin supplementation increased GLP-1 levels by 22% and improved markers of glucose metabolism in pre-diabetic adults.⁴

For perimenopausal women experiencing reduced GLP-1 signaling due to estrogen decline, supporting endogenous GLP-1 production addresses one of the specific hormonal pathways driving appetite changes. This is a mechanism-based rationale. No trial has been conducted specifically in perimenopausal women with Eriomin, but the GLP-1 pathway is directly relevant to the appetite changes of this transition.

B420 and Appetite Regulation

Bifidobacterium animalis subsp. lactis B420 has been studied for its effects on body composition and energy intake. In a 6-month randomized controlled trial of 225 overweight adults, B420 supplementation reduced body fat mass and was associated with a reduction in energy intake. The trial also reported improved insulin sensitivity, suggesting that B420 may influence the metabolic signaling that contributes to hunger and cravings.

The mechanism by which B420 affects appetite likely involves the gut microbiome's role in producing short-chain fatty acids, which influence satiety signaling through the gut-brain axis. The trial population was general overweight adults, not specifically perimenopausal women.

Fiber and Satiety

Soluble fiber supplements, including psyllium and glucomannan, have evidence for increasing satiety and reducing energy intake. A meta-analysis of randomized controlled trials found that soluble fiber supplementation reduced appetite and body weight over periods of 4 to 12 weeks.⁵

Fiber works through multiple mechanisms. It delays gastric emptying, which extends the feeling of fullness. It is fermented by gut bacteria into short-chain fatty acids that influence appetite hormones. And it stabilizes blood glucose, reducing the post-meal crashes that can trigger cravings.

Fiber is a useful adjunct to targeted appetite supplements, but it addresses appetite through physical and fermentative mechanisms rather than the hormonal pathways most affected by perimenopause.

Protein and Satiety

Protein supplementation has strong evidence for increasing satiety. A systematic review and meta-analysis found that high-protein diets and protein supplementation increased satiety and reduced energy intake compared to normal-protein controls.⁶ Protein triggers the release of satiety hormones including GLP-1, PYY, and cholecystokinin.

For perimenopausal women, adequate protein intake supports both appetite regulation and muscle preservation, which is relevant given the muscle loss that accompanies hormonal decline.

What to Look for in an Appetite Supplement for Perimenopause

Several criteria help distinguish products designed with mechanism-specific targeting from generic appetite suppressants.

Mechanism identification. A product should specify which appetite pathway it targets. Eriomin targets GLP-1 production. B420 targets gut-mediated satiety signaling. Generic blends without mechanism identification cannot be matched to the specific hormonal changes of perimenopause.

Named strains and ingredients. Products that name specific strains and compounds, rather than listing only CFU counts or proprietary blend labels, allow you to connect the formula to published evidence. WONDERBIOTICS combines B420 for body composition and appetite regulation with Eriomin for GLP-1 support. Each ingredient is identified and linked to a specific function. You can learn more about the full formulation on the WONDERBIOTICS blog.

Delivery technology. For probiotic-based appetite supplements, strain survival through gastric acid is essential. WONDERBIOTICS uses PolarSeal Technology, which in testing showed 99.9% strain survival in gut-like acidic conditions and 98.2% bacterial viability through the point of consumption. These are test results, not measurements of in-vivo survival through the full digestive tract.

Ingredient-level evidence depth. The core ingredients in the WONDERBIOTICS formula are backed by 624 clinical studies involving 44,692 participants. This is ingredient-level evidence, not finished-product data. Each ingredient has been studied individually.

What Supplements Cannot Replace

Appetite supplements for perimenopause work within the context of foundational lifestyle factors. No supplement can substitute for adequate sleep, which directly affects ghrelin and leptin levels. Research shows that sleep deprivation increases ghrelin by approximately 28% and decreases leptin by approximately 18%, creating a hormonal environment that drives hunger.⁷

Stress management is equally relevant. Cortisol, the primary stress hormone, increases appetite and promotes abdominal fat storage. The perimenopausal transition is a period of significant physiological and life stress for many women, and chronic stress amplifies the appetite changes driven by hormonal fluctuations.

Regular meals with adequate protein, fiber, and healthy fats provide the nutritional foundation that allows appetite-regulating supplements to work effectively. Skipping meals or relying on highly processed foods disrupts blood glucose stability and undermines the hormonal balance that supplements aim to support.

Practical Takeaways

The appetite changes of perimenopause follow identifiable hormonal pathways: increased ghrelin sensitivity, reduced leptin signaling, and decreased GLP-1 production. Supplements that target these specific mechanisms offer the most rational approach to managing perimenopause hunger.

When evaluating a product, look for named ingredients with mechanism-specific evidence, delivery technology that protects strains through gastric acid, and a formula where each ingredient addresses a defined appetite pathway. Talk with your clinician before starting any new supplement, particularly if you take medications for blood glucose, mood, or hormonal regulation.

This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. If you have symptoms, a medical condition, are pregnant or breastfeeding, or take medications, talk with a licensed clinician before making health changes or starting supplements.

References

1. Dafopoulos K, Sourlas D, Kallianidis K, et al. Ghrelin and leptin levels in premenopausal and postmenopausal women. Maturitas. 2009;63(2):125-130. https://pubmed.ncbi.nlm.nih.gov/19201552/
2. Pannacciulli N, Bunt JC, Ortega E, et al. Lower total and central fat mass and leptin secretion are associated with lower leptin concentrations before and after weight loss in menopausal women. J Clin Endocrinol Metab. 2008;93(6):2355-2361. https://pubmed.ncbi.nlm.nih.gov/18381583/
3. Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and the primary prevention of cardiovascular disease. Lancet Diabetes Endocrinol. 2018;6(9):727-738. https://pubmed.ncbi.nlm.nih.gov/30033073/
4. Burbank J, Sandberg A, Hwang M, et al. Eriomin supplementation increases GLP-1 levels and improves glucose tolerance. J Nutr Biochem. 2024;125:109558. https://pubmed.ncbi.nlm.nih.gov/38043032/
5. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434-445. https://pubmed.ncbi.nlm.nih.gov/30638909/
6. Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015;101(6):1320S-1329S. https://academic.oup.com/ajcn/article/101/6/1320S/4564494
7. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. https://pubmed.ncbi.nlm.nih.gov/15583226/
8. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab. 2004;287(2):E297-E304. https://pubmed.ncbi.nlm.nih.gov/15044219/